Table of Contents

Select this article
- M Fernández-Castañer,
- A Molina,
- L López-Jiménez,
- J M Gómez,
- and J Soler
Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity.
Diabetes Care March 1999 22:377-381; doi:10.2337/diacare.22.3.377
- Abstract
- Full Text (PDF)
Select this article
- S D Ramsey,
- K Newton,
- D Blough,
- D K McCulloch,
- N Sandhu,
- G E Reiber,
- and E H Wagner
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
Diabetes Care March 1999 22:382-387; doi:10.2337/diacare.22.3.382
- Abstract
- Full Text (PDF)
Select this article
- M Ducher,
- C Cerutti,
- M P Gustin,
- S Abou-Amara,
- C Thivolet,
- M Laville,
- C Z Paultre,
- and J P Fauvel
Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes?
Diabetes Care March 1999 22:388-393; doi:10.2337/diacare.22.3.388
- Abstract
- Full Text (PDF)
Select this article
- R L Ollerton,
- R Playle,
- K Ahmed,
- F D Dunstan,
- S D Luzio,
- and D R Owens
Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.
Diabetes Care March 1999 22:394-398; doi:10.2337/diacare.22.3.394
- Abstract
- Full Text (PDF)
Select this article
- J E Shaw,
- P Z Zimmet,
- M de Courten,
- G K Dowse,
- P Chitson,
- H Gareeboo,
- F Hemraj,
- D Fareed,
- J Tuomilehto,
- and K G Alberti
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
Diabetes Care March 1999 22:399-402; doi:10.2337/diacare.22.3.399
- Abstract
- Full Text (PDF)
Select this article
- M I Harris,
- R C Eastman,
- C C Cowie,
- K M Flegal,
- and M S Eberhardt
Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
Diabetes Care March 1999 22:403-408; doi:10.2337/diacare.22.3.403
- Abstract
- Full Text (PDF)
Select this article
- B Littorin,
- G Sundkvist,
- W Hagopian,
- M Landin-Olsson,
- A Lernmark,
- J Ostman,
- H J Arnqvist,
- G Blohmé,
- J Bolinder,
- J W Eriksson,
- F Lithner,
- B Scherstén,
- and L Wibell
Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.
Diabetes Care March 1999 22:409-412; doi:10.2337/diacare.22.3.409
- Abstract
- Full Text (PDF)
Select this article
- C Fox,
- J Esparza,
- M Nicolson,
- P H Bennett,
- L O Schulz,
- M E Valencia,
- and E Ravussin
Plasma leptin concentrations in Pima Indians living in drastically different environments.
Diabetes Care March 1999 22:413-417; doi:10.2337/diacare.22.3.413
- Abstract
- Full Text (PDF)
Select this article
- C B Williams,
- S Iqbal,
- C M Zawacki,
- D Yu,
- M B Brown,
- and W H Herman
Effect of selective screening for gestational diabetes.
Diabetes Care March 1999 22:418-421; doi:10.2337/diacare.22.3.418
- Abstract
- Full Text (PDF)
Select this article
- R S Lindsay,
- J Little,
- A J Jaap,
- P L Padfield,
- J D Walker,
- and K J Hardy
Diabetic nephropathy is associated with an increased familial risk of stroke.
Diabetes Care March 1999 22:422-425; doi:10.2337/diacare.22.3.422
- Abstract
- Full Text (PDF)
Select this article
- B L Chapin,
- S Medina,
- D Le,
- N Bussell,
- and K Bussell
Prevalence of undiagnosed diabetes and abnormalities of carbohydrate metabolism in a U.S. Army population.
Diabetes Care March 1999 22:426-429; doi:10.2337/diacare.22.3.426
- Abstract
- Full Text (PDF)
Select this article
- J Pomerleau,
- P M McKeigue,
- and N Chaturvedi
Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women?
Diabetes Care March 1999 22:430-433; doi:10.2337/diacare.22.3.430
- Abstract
- Full Text (PDF)
Select this article
- J C Mbanya,
- J K Cruickshank,
- T Forrester,
- B Balkau,
- J Y Ngogang,
- L Riste,
- A Forhan,
- N M Anderson,
- F Bennett,
- and R Wilks
Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain.
Diabetes Care March 1999 22:434-440; doi:10.2337/diacare.22.3.434
- Abstract
- Full Text (PDF)
Select this article
- K J Greenlund,
- R Valdèz,
- M L Casper,
- S Rith-Najarian,
- and J B Croft
Prevalence and correlates of the insulin resistance syndrome among Native Americans. The Inter-Tribal Heart Project.
Diabetes Care March 1999 22:441-447; doi:10.2337/diacare.22.3.441
- Abstract
- Full Text (PDF)
Select this article
- M Peyrot and
- R R Rubin
Persistence of depressive symptoms in diabetic adults.
Diabetes Care March 1999 22:448-452; doi:10.2337/diacare.22.3.448
- Abstract
- Full Text (PDF)
Select this article
- A S MacGregor,
- J F Price,
- C M Hau,
- A J Lee,
- M N Carson,
- and F G Fowkes
Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study.
Diabetes Care March 1999 22:453-458; doi:10.2337/diacare.22.3.453
- Abstract
- Full Text (PDF)
Select this article
- V A Koivisto,
- J A Tuominen,
- and P Ebeling
Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.
Diabetes Care March 1999 22:459-462; doi:10.2337/diacare.22.3.459
- Abstract
- Full Text (PDF)
Select this article
- B H Wolffenbuttel and
- R Landgraf
A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.
Diabetes Care March 1999 22:463-467; doi:10.2337/diacare.22.3.463
- Abstract
- Full Text (PDF)
Select this article
- C Lalli,
- M Ciofetta,
- P Del Sindaco,
- E Torlone,
- S Pampanelli,
- P Compagnucci,
- M G Cartechini,
- L Bartocci,
- P Brunetti,
- and G B Bolli
Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.
Diabetes Care March 1999 22:468-477; doi:10.2337/diacare.22.3.468
- Abstract
- Full Text (PDF)
Select this article
- H H Parving,
- L Tarnow,
- F S Nielsen,
- P Rossing,
- T Mandrup-Poulsen,
- R Osterby,
- and J Nerup
Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.
Diabetes Care March 1999 22:478-483; doi:10.2337/diacare.22.3.478
- Abstract
- Full Text (PDF)
Select this article
- E Okada,
- K Oida,
- H Tada,
- K Asazuma,
- K Eguchi,
- G Tohda,
- S Kosaka,
- S Takahashi,
- and I Miyamori
Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.
Diabetes Care March 1999 22:484-490; doi:10.2337/diacare.22.3.484
- Abstract
- Full Text (PDF)
Select this article
- L Tarnow,
- A Sato,
- S Ali,
- P Rossing,
- F S Nielsen,
- and H H Parving
Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.
Diabetes Care March 1999 22:491-494; doi:10.2337/diacare.22.3.491
- Abstract
Select this article
- C J Schultz,
- T Konopelska-Bahu,
- R N Dalton,
- T A Carroll,
- I Stratton,
- E A Gale,
- A Neil,
- and D B Dunger
Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.
Diabetes Care March 1999 22:495-502; doi:10.2337/diacare.22.3.495
- Abstract
- Full Text (PDF)
Select this article
- M F Kong,
- M Horowitz,
- K L Jones,
- J M Wishart,
- and P E Harding
Natural history of diabetic gastroparesis.
Diabetes Care March 1999 22:503-507; doi:10.2337/diacare.22.3.503
- Abstract
- Full Text (PDF)
- M A Safran and
- F Vinicor
The war against diabetes. How will we know if we are winning?
Diabetes Care March 1999 22:508-516; doi:10.2337/diacare.22.3.508
- Full Text (PDF)
- Z T Bloomgarden
American Diabetes Association Annual Meeting, 1998. Insulin resistance, exercise, and obesity.
Diabetes Care March 1999 22:517-522; doi:10.2337/diacare.22.3.517
- Full Text (PDF)
- A Kawakami,
- S Nagasaka,
- K Rokkaku,
- T Nakamura,
- I Kusaka,
- Y Yajima,
- S Ishikawa,
- and T Saito
Pseudohypoparathyroidism, obesity, and type 2 diabetes. A hypothesis.
Diabetes Care March 1999 22:523; doi:10.2337/diacare.22.3.523
- Full Text (PDF)
- R A Hegele,
- H Cao,
- S B Harris,
- A J Hanley,
- and B Zinman
Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.
Diabetes Care March 1999 22:524; doi:10.2337/diacare.22.3.524b
- Full Text (PDF)
- M Lidar,
- R Rachmani,
- E Half,
- and M Ravid
Insulin autoimmune syndrome after therapy with imipenem.
Diabetes Care March 1999 22:524-525; doi:10.2337/diacare.22.3.524a
- Full Text (PDF)
- J M Fernandez-Real,
- J Vendrell,
- M Baiget,
- E Gimferrer,
- and W Ricart
C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes.
Diabetes Care March 1999 22:525-526; doi:10.2337/diacare.22.3.525
- Full Text (PDF)
- F Guerrero-Romeo,
- M Rodríguez-Morán,
- and R Alvarado-Ruiz
Concordance between the 1997 fasting American Diabetes Association criteria and the World Health Organization criteria in healthy Mexican subjects.
Diabetes Care March 1999 22:527; doi:10.2337/diacare.22.3.527
- Full Text (PDF)
- R Vanamo
Metformin as adjuvant to insulin therapy in type 2 diabetic patients.
Diabetes Care March 1999 22:528; doi:10.2337/diacare.22.3.528b
- Full Text (PDF)
- T A Elhadd,
- R W Newton,
- P E Jennings,
- and J J Belch
Antioxidant effects of gliclazide and soluble adhesion molecules in type 2 diabetes.
Diabetes Care March 1999 22:528-530; doi:10.2337/diacare.22.3.528a
- Full Text (PDF)
- C Bradley
Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur.
Diabetes Care March 1999 22:530-532; doi:10.2337/diacare.22.3.530
- Full Text (PDF)
- A L Peters,
- R Henry,
- S V Edelman,
- and B J Goldstein
Keep metformin guidelines intact.
Diabetes Care March 1999 22:532-533; doi:10.2337/diacare.22.3.532
- Full Text (PDF)
- A G Tabák,
- Z Kerényi,
- J Pénzes,
- and G Tamás
Poor level of care among diabetic patients. Is that a unique picture?
Diabetes Care March 1999 22:533-535; doi:10.2337/diacare.22.3.533
- Full Text (PDF)
- T A Buchanan
Screening low-risk women for gestational diabetes mellitus. Let's not muddy the waters further.
Diabetes Care March 1999 22:535; doi:10.2337/diacare.22.3.535
- Full Text (PDF)

Diabetes Care

Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity.

Incidence, outcomes, and cost of foot ulcers in patients with diabetes.

Noninvasive exploration of cardiac autonomic neuropathy. Four reliable methods for diabetes?

Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects.

Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?

Racial and ethnic differences in glycemic control of adults with type 2 diabetes.

Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.

Plasma leptin concentrations in Pima Indians living in drastically different environments.

Effect of selective screening for gestational diabetes.

Diabetic nephropathy is associated with an increased familial risk of stroke.

Prevalence of undiagnosed diabetes and abnormalities of carbohydrate metabolism in a U.S. Army population.

Relationships of fasting and postload glucose levels to sex and alcohol consumption. Are American Diabetes Association criteria biased against detection of diabetes in women?

Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain.

Prevalence and correlates of the insulin resistance syndrome among Native Americans. The Inter-Tribal Heart Project.

Persistence of depressive symptoms in diabetic adults.

Role of systolic blood pressure and plasma triglycerides in diabetic peripheral arterial disease. The Edinburgh Artery Study.

Lispro Mix25 insulin as premeal therapy in type 2 diabetic patients.

A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group.

Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study.

Hyperhomocysteinemia is a risk factor for coronary arteriosclerosis in Japanese patients with type 2 diabetes.

Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.

Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.

Natural history of diabetic gastroparesis.

The war against diabetes. How will we know if we are winning?

American Diabetes Association Annual Meeting, 1998. Insulin resistance, exercise, and obesity.

Pseudohypoparathyroidism, obesity, and type 2 diabetes. A hypothesis.

Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.

Insulin autoimmune syndrome after therapy with imipenem.

C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes.

Concordance between the 1997 fasting American Diabetes Association criteria and the World Health Organization criteria in healthy Mexican subjects.

Metformin as adjuvant to insulin therapy in type 2 diabetic patients.

Antioxidant effects of gliclazide and soluble adhesion molecules in type 2 diabetes.

Diabetes treatment satisfaction questionnaire. Change version for use alongside status version provides appropriate solution where ceiling effects occur.

Keep metformin guidelines intact.

Poor level of care among diabetic patients. Is that a unique picture?

Screening low-risk women for gestational diabetes mellitus. Let's not muddy the waters further.

This Issue

Current Issue

From the Cover